NTRK Alterations in Pediatric High-Risk Malignancies Identified Through European Clinical Sequencing Programs Constitute Promising Drug Targets

Elke Pfaff, Tiphaine Adam de Beaumais, Antonin Marchais, Cornelis M. van Tilburg, Mirjam Blattner-Johnson, Uta Dirksen, Ingrid Øra, Birgit Geoerger, Gudrun Schleiermacher, Stefan M. Pfister, Olaf Witt, David T. W. Jones, Gilles Vassal